What was Alexandria Pharmaceuticals's net profit in 2026?

Alexandria Pharmaceuticals's net profit in 2026 was 660 million EGP, up 1131.7% from 53.59 million EGP in 2025. Source: annual statements 2026.

What were Alexandria Pharmaceuticals's total assets and shareholders' equity in 2026?

Total assets at the end of 2026 were 1.78 billion EGP, and shareholders' equity 1.18 billion EGP. Source: annual statements 2026.

Was Alexandria Pharmaceuticals's operating cash flow positive in 2026?

Operating cash flow in 2026 was positive at 522 million EGP. Source: annual statements 2026.

EGX·Health Care & Pharmaceuticals

Alexandria Pharmaceuticals

AXPH

Fiscal year starts in July · currency EGP · latest: Annual 2026

Next results: Q1 2027 — expected around 15 November 2026published last year on 13 November 2025Results calendar ←

1,315.98EGP+0.07% today1w +3.9%1m −14.3%delayed · 3 November

Net profit · 2026

660million

▲ 1131.7% vs 2025

Total assets · 2026

1.78billion

Shareholders' equity · 2026

1.18billion

▲ 18.6% vs 2025

Operating cash flow · 2026

522million

Key facts

Source: annual statements 2026

Alexandria Pharmaceuticals's net profit in 2026 was 660 million EGP, up 1131.7% from 53.59 million EGP in 2025.
Total assets at the end of 2026 were 1.78 billion EGP, and shareholders' equity 1.18 billion EGP.
Operating cash flow in 2026 was positive at 522 million EGP.

Alexandria Pharmaceuticals's Q1 2027 results are expected around 15 November — we email you the day they land

One email on the day, no account, and a one-click stop in the email itself.

orFollow on TelegramEvery result as it lands, in the @askborsa channel

By subscribing you agree to receive these alerts only. Privacy policy

AI summary

Preparing a summary of the latest results…

Ask about Alexandria Pharmaceuticals

How much did Alexandria Pharmaceuticals's net profit grow last year?What were total assets and shareholders' equity in the latest annual balance sheet?Was operating cash flow positive in the last three years?Type your question…Ask

3 free questions a day after signing up. With Google, no password.

Annual net profit last 7 years

Net profit

170million

117million

126million

217million

53.59million

660million

2020202120222023202420252026

Summarised financial statements

Excel · Pro

Swipe the table to see the other years.

Item · EGP2020202120222023202420252026

Income statement

Net profit170 million117 million117 million126 million217 million53.59 million660 million

Gross profit344 million293 million461 million295 million613 million98.72 million1.35 billion

Total assets799 million793 million875 million923 million1.24 billion—1.78 billion

Total liabilities227 million207 million245 million263 million446 million—597 million

Shareholders' equity572 million586 million630 million660 million795 million994 million1.18 billion

Total liabilities and equity799 million793 million875 million923 million1.24 billion1.53 billion1.78 billion

Operating cash flow140 million99.42 million193 million91.34 million190 million—522 million

Investing cash flow-60.02 million-114 million-26.6 million-77.84 million-48.33 million—-67.15 million

Financing cash flow-78.08 million-100 million-64.52 million-76.94 million-82 million—-343 million

Net change in cash1.7 million-114 million102 million-63.44 million59.3 million—111 million

With Google or your email, no password.

Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. What does this line mean?

Results by period

One page per period: the figures against the same period a year earlier, and the official report.

Alexandria Pharmaceuticals

Key facts

Alexandria Pharmaceuticals's Q1 2027 results are expected around 15 November — we email you the day they land

Summarised financial statements

Results by period

Financial reports (17)

Other companies in Health Care & Pharmaceuticals